Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation.
about
A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasionp53 in cell invasion, podosomes, and invadopodiaiTRAQ proteomic identification of pVHL-dependent and -independent targets of Egln1 prolyl hydroxylase knockdown in renal carcinoma cells.Cellular processes of v-Src transformation revealed by gene profiling of primary cells--implications for human cancer.Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability.Development of an integrated genomic classifier for a novel agent in colorectal cancer: approach to individualized therapy in early development.Caldesmon and the regulation of cytoskeletal functions.Podosomes and Invadopodia: Related structures with Common Protein Components that May Promote Breast Cancer Cellular Invasion.Caldesmon as a therapeutic target for proliferative vascular diseases.Caldesmon regulates actin dynamics to influence cranial neural crest migration in Xenopus.NHERF1 acts as a molecular switch to program metastatic behavior and organotropism via its PDZ domains.Cyclin-Dependent Kinase 5 (CDK5) Controls Melanoma Cell Motility, Invasiveness, and Metastatic Spread-Identification of a Promising Novel therapeutic target.Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer.cGMP-dependent protein kinase Iβ regulates breast cancer cell migration and invasion via interaction with the actin/myosin-associated protein caldesmon.Glucocorticoid receptor-mediated expression of caldesmon regulates cell migration via the reorganization of the actin cytoskeleton.Quantitative global proteome and lysine succinylome analyses provide insights into metabolic regulation and lymph node metastasis in gastric cancer.New insights into the regulation of the actin cytoskeleton by tropomyosin.Diversification of caldesmon-linked actin cytoskeleton in cell motility.Doubles game: Src-Stat3 versus p53-PTEN in cellular migration and invasion.p53 regulates cytoskeleton remodeling to suppress tumor progression.Leupaxin stimulates adhesion and migration of prostate cancer cells through modulation of the phosphorylation status of the actin-binding protein caldesmon.Functions of the Tumor Suppressors p53 and Rb in Actin Cytoskeleton RemodelingAutoantibody signatures as biomarkers to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate specific antigen.Myocardin-related transcription factor A (MRTF-A) activity-dependent cell adhesion is correlated to focal adhesion kinase (FAK) activity.p53 suppresses Src-induced podosome and rosette formation and cellular invasiveness through the upregulation of caldesmon.Cortactin function in invadopodia.The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature.Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer
P2860
Q24627610-792E0555-7D8F-48EA-9B21-8E2502883992Q33358202-D9852F7F-0729-4E86-84B1-A87E052E2869Q33401743-DCFDC974-5155-4D88-9CA1-CEE5106A7A0BQ33530940-429E1F2A-A2D6-4392-8220-5D2EE1441FCCQ33758888-3708F6D1-A0A6-42E8-AF1C-4D42F67EDA1DQ33927952-23DDE5D8-FBF1-4AEA-89DC-87608DC61BF4Q34284851-5DCC346F-92D2-4FD2-A151-80927537D95BQ34897371-102FFF9D-CA6E-4797-B9E6-E35BD27919EEQ35065851-8D41408C-968B-4EB2-87D0-86D8A38D3E4FQ35210983-4E50EE89-5882-40EF-B0FA-BA371E6D3A60Q35998570-3DC21F0F-1190-4B4F-8642-7A6A6EDA75F8Q36037996-0E897D21-0698-44D2-BA8E-132D837FCA42Q36545629-A36F1ADF-BCD4-40C1-A24C-B5D6FBFF63A3Q36772047-7EFB8C28-227D-4867-BE81-1F23E089DE93Q36825244-568C6ACD-DA2D-48EE-8C99-BB137192AB53Q37142731-5F1E3754-6DD1-4DEF-9A11-6B971EDB3FA8Q37625637-C9790194-CFF3-47E8-AB5E-CB5BA26538FCQ37749050-5CA0A89A-402E-4F16-81EA-14F22B842CFDQ37847039-0B543375-D756-466A-B689-637F3D21A99BQ38341405-F711631A-666F-4C22-9897-C3EE14F712A5Q38553239-752E6934-B0E2-4D1D-8E4B-AAB0623B5FE7Q38863488-88AC25BA-CB7B-4D02-94C2-D9FB6CB06E95Q39080969-FC46E60D-2400-4FC3-81CE-5060E6712448Q40747388-C43BEBCF-73C8-43F9-A994-1F7E022CA128Q41816916-F52D09D1-3285-4ABC-BE7D-568B666913F2Q41921175-F723DD62-F1DC-45FA-8758-00BA081B8294Q47367433-4EBE5BF5-F6E6-4591-8EF0-0C3081BDED0CQ53692873-50248C4C-267B-4B01-B3B7-919DBB471F8DQ59138133-5634F3C3-9DCD-4069-B73D-705B2E3C2E74
P2860
Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation.
@en
type
label
Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation.
@en
prefLabel
Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation.
@en
P2093
P2860
P1433
P1476
Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation.
@en
P2093
P2860
P304
P356
10.1016/J.FEBSLET.2007.06.073
P407
P577
2007-07-05T00:00:00Z